Kantum Bio's Debt - II Round

Kantum Bio raised a round of funding on October 12, 2018.

Kantum Diagnostics, dba Kantum Bio, is developing two programs in parallel: (1) Selective receptor antagonist-based therapeutics for AKI and (2) a UDP-G diagnostic test. Kantum's lead therapeutic deve…

Articles about Kantum Bio's Debt - II Round: